Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
38.00
+3.10 (8.88%)
May 12, 2025, 5:01 PM CET
-44.36%
Market Cap 697.51M
Revenue (ttm) 345.76M
Net Income (ttm) -6.10M
Shares Out 18.36M
EPS (ttm) -0.33
PE Ratio n/a
Forward PE 30.04
Dividend n/a
Ex-Dividend Date n/a
Volume 37,932
Average Volume 16,272
Open 35.20
Previous Close 34.90
Day's Range 35.20 - 38.40
52-Week Range 29.90 - 73.00
Beta 0.08
RSI 60.88
Earnings Date May 22, 2025

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.